Active Biotech wins Japan patent for laquinimod eye-drop formulation until 2042
Active Biotech secured a Japan patent for an ophthalmic laquinimod formulation, granting potential exclusivity in Japan until 2042 under patent number 7,918,190.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.